Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. R. Howe
Pioglitazone, a PPAR Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Related publications
15-Hydroxyprostaglandin Dehydrogenase (15-Pgdh) and Lung Cancer
Prostaglandins and Other Lipid Mediators
Biochemistry
Cell Biology
Pharmacology
Physiology
The PPAR Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression
American Journal of Pathology
Forensic Medicine
Pathology
Loss of 15-Hydroxyprostaglandin Dehydrogenase Increases Prostaglandin E2 in Pancreatic Tumors
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Apoptosis Rate and Transcriptional Response of Pancreatic Islets Exposed to the PPAR Gamma Agonist Pioglitazone
Diabetology and Metabolic Syndrome
Internal Medicine
Endocrinology
Metabolism
Diabetes
Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer
Cancer Research
Cancer Research
Oncology
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
Journal of Immunology
Allergy
Immunology
A Potential Anti-Tumor Effect of Leukotriene C4 Through the Induction of 15-Hydroxyprostaglandin Dehydrogenase Expression in Colon Cancer Cells
Oncotarget
Oncology
Reduced Expression of Hydrogen Sulfide–Generating Enzymes Down-Regulates 15-Hydroxyprostaglandin Dehydrogenase in Chorion During Term and Preterm Labor
American Journal of Pathology
Forensic Medicine
Pathology
